Food News and Research

RSS
First Salmonella lawsuit filed against Yum Brands

First Salmonella lawsuit filed against Yum Brands

BioSpecifics Technologies second-quarter total revenues decrease to $0.9 million

BioSpecifics Technologies second-quarter total revenues decrease to $0.9 million

New superfood Ideal Omega Taste launched with free 'Omega Ice Cream' giveaway

New superfood Ideal Omega Taste launched with free 'Omega Ice Cream' giveaway

Osiris Therapeutics reports second-quarter net income of $1.7M against loss last year

Osiris Therapeutics reports second-quarter net income of $1.7M against loss last year

Multimedia programs increase vegetable intake in kindergarten children

Multimedia programs increase vegetable intake in kindergarten children

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

FDA confirms Advisory Committee meeting date for lorcaserin NDA review

FDA confirms Advisory Committee meeting date for lorcaserin NDA review

FDA seeks ban on Regenerative Sciences for violating cGMP

FDA seeks ban on Regenerative Sciences for violating cGMP

Alkermes reports $42.3 million revenue for first-quarter fiscal 2011

Alkermes reports $42.3 million revenue for first-quarter fiscal 2011

Cyclacel second-quarter net loss decreases to $6.5 million

Cyclacel second-quarter net loss decreases to $6.5 million

Arena Pharmaceuticals to sell common stock shares to Deerfield Management

Arena Pharmaceuticals to sell common stock shares to Deerfield Management

Senate gives final passage to state aid bill, House summoned for Tuesday vote

Senate gives final passage to state aid bill, House summoned for Tuesday vote

FDA approves Lannett's ANDA for Ondansetron Injection

FDA approves Lannett's ANDA for Ondansetron Injection

FDA declines to grant Levulan PDT Orphan Designation: DUSA Pharmaceuticals

FDA declines to grant Levulan PDT Orphan Designation: DUSA Pharmaceuticals

AVANIR Pharmaceuticals reports net loss of $5.7M for third-quarter fiscal 2010

AVANIR Pharmaceuticals reports net loss of $5.7M for third-quarter fiscal 2010

Recent releases in Global Health

Recent releases in Global Health

FDA proposed rules address industry, consumer concerns

FDA proposed rules address industry, consumer concerns

Poor countries need assistance developing sustainable agricultural systems, USDA Undersecretary says

Poor countries need assistance developing sustainable agricultural systems, USDA Undersecretary says

Nemours applauds Senate for passing bi-partisan Healthy, Hunger-Free Kids Act of 2010

Nemours applauds Senate for passing bi-partisan Healthy, Hunger-Free Kids Act of 2010

Risk of epidemic is high in Pakistan: Canadian Red Cross

Risk of epidemic is high in Pakistan: Canadian Red Cross

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.